Mar 1 |
Biodesix, Inc. (BDSX) Q4 2023 Earnings Call Transcript
|
Mar 1 |
Biodesix Inc (BDSX) Reports Strong Growth in Lung Diagnostic Test Volume and Gross Profit Margin
|
Mar 1 |
Biodesix GAAP EPS of -$0.10, revenue of $14.7M
|
Mar 1 |
Biodesix: Q4 Earnings Insights
|
Mar 1 |
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
|
Feb 26 |
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
|
Feb 16 |
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
|
Feb 13 |
Biodesix Inc CEO Scott Hutton Sells 64,390 Shares
|
Feb 2 |
One Biodesix Insider Raised Their Stake In The Previous Year
|
Jan 26 |
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
|